nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HTR2C—choroid plexus—malignant glioma	0.0568	0.126	CbGeAlD
Thioridazine—CYP1A2—Carmustine—malignant glioma	0.0315	1	CbGbCtD
Thioridazine—HTR2A—choroid plexus—malignant glioma	0.0285	0.0633	CbGeAlD
Thioridazine—DRD1—telencephalic ventricle—malignant glioma	0.0214	0.0476	CbGeAlD
Thioridazine—HTR2C—telencephalic ventricle—malignant glioma	0.0166	0.037	CbGeAlD
Thioridazine—HTR7—pons—malignant glioma	0.0163	0.0361	CbGeAlD
Thioridazine—HTR2A—cerebellar cortex—malignant glioma	0.0143	0.0319	CbGeAlD
Thioridazine—HTR1A—telencephalic ventricle—malignant glioma	0.014	0.0311	CbGeAlD
Thioridazine—HTR7—telencephalic ventricle—malignant glioma	0.0134	0.0297	CbGeAlD
Thioridazine—DRD2—telencephalic ventricle—malignant glioma	0.0126	0.0281	CbGeAlD
Thioridazine—HTR2A—pons—malignant glioma	0.0101	0.0225	CbGeAlD
Thioridazine—HTR2A—vertebral column—malignant glioma	0.0101	0.0224	CbGeAlD
Thioridazine—HTR2A—telencephalic ventricle—malignant glioma	0.00834	0.0185	CbGeAlD
Thioridazine—HTR2A—pineal body—malignant glioma	0.00724	0.0161	CbGeAlD
Thioridazine—HTR7—endothelium—malignant glioma	0.00718	0.016	CbGeAlD
Thioridazine—HTR6—telencephalon—malignant glioma	0.00691	0.0154	CbGeAlD
Thioridazine—HTR7—blood vessel—malignant glioma	0.00662	0.0147	CbGeAlD
Thioridazine—Trifluoperazine—CALY—malignant glioma	0.00647	0.372	CrCbGaD
Thioridazine—DRD1—brainstem—malignant glioma	0.00579	0.0129	CbGeAlD
Thioridazine—DRD1—telencephalon—malignant glioma	0.00514	0.0114	CbGeAlD
Thioridazine—HTR2C—brainstem—malignant glioma	0.0045	0.01	CbGeAlD
Thioridazine—HTR2A—endothelium—malignant glioma	0.00448	0.00995	CbGeAlD
Thioridazine—Hepatotoxicity—Carmustine—malignant glioma	0.00442	0.0434	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00438	0.043	CcSEcCtD
Thioridazine—Cholestasis—Temozolomide—malignant glioma	0.00435	0.0427	CcSEcCtD
Thioridazine—Hepatotoxicity—Temozolomide—malignant glioma	0.00427	0.042	CcSEcCtD
Thioridazine—CHRM2—telencephalon—malignant glioma	0.00414	0.00921	CbGeAlD
Thioridazine—HTR2A—blood vessel—malignant glioma	0.00413	0.00918	CbGeAlD
Thioridazine—HTR2C—telencephalon—malignant glioma	0.00399	0.00888	CbGeAlD
Thioridazine—HTR6—central nervous system—malignant glioma	0.00393	0.00873	CbGeAlD
Thioridazine—HTR1A—brainstem—malignant glioma	0.00379	0.00842	CbGeAlD
Thioridazine—Amenorrhoea—Temozolomide—malignant glioma	0.00376	0.0369	CcSEcCtD
Thioridazine—DRD1—midbrain—malignant glioma	0.00369	0.00821	CbGeAlD
Thioridazine—HTR7—brainstem—malignant glioma	0.00362	0.00805	CbGeAlD
Thioridazine—ADRA1A—brainstem—malignant glioma	0.00349	0.00776	CbGeAlD
Thioridazine—DRD2—brainstem—malignant glioma	0.00342	0.00761	CbGeAlD
Thioridazine—HTR1A—telencephalon—malignant glioma	0.00336	0.00747	CbGeAlD
Thioridazine—DRD2—retina—malignant glioma	0.0033	0.00734	CbGeAlD
Thioridazine—HTR7—telencephalon—malignant glioma	0.00321	0.00714	CbGeAlD
Thioridazine—HTR2C—medulla oblongata—malignant glioma	0.00314	0.00697	CbGeAlD
Thioridazine—ADRA1B—central nervous system—malignant glioma	0.00313	0.00697	CbGeAlD
Thioridazine—HTR6—brain—malignant glioma	0.00312	0.00693	CbGeAlD
Thioridazine—ADRA1A—telencephalon—malignant glioma	0.0031	0.00689	CbGeAlD
Thioridazine—Aplastic anaemia—Temozolomide—malignant glioma	0.0031	0.0304	CcSEcCtD
Thioridazine—Gynaecomastia—Carmustine—malignant glioma	0.00306	0.03	CcSEcCtD
Thioridazine—DRD2—telencephalon—malignant glioma	0.00304	0.00675	CbGeAlD
Thioridazine—KCNH2—telencephalon—malignant glioma	0.00299	0.00665	CbGeAlD
Thioridazine—DRD1—central nervous system—malignant glioma	0.00292	0.00649	CbGeAlD
Thioridazine—HTR2C—midbrain—malignant glioma	0.00287	0.00637	CbGeAlD
Thioridazine—HTR2C—spinal cord—malignant glioma	0.0028	0.00622	CbGeAlD
Thioridazine—Nasal congestion—Temozolomide—malignant glioma	0.00263	0.0258	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00254	0.0249	CcSEcCtD
Thioridazine—HTR7—medulla oblongata—malignant glioma	0.00252	0.00561	CbGeAlD
Thioridazine—ADRA1B—brain—malignant glioma	0.00249	0.00553	CbGeAlD
Thioridazine—HTR2A—embryo—malignant glioma	0.00246	0.00547	CbGeAlD
Thioridazine—HTR1A—midbrain—malignant glioma	0.00241	0.00537	CbGeAlD
Thioridazine—HRH1—telencephalon—malignant glioma	0.0024	0.00533	CbGeAlD
Thioridazine—ADRA2A—telencephalon—malignant glioma	0.00236	0.00524	CbGeAlD
Thioridazine—HTR1A—spinal cord—malignant glioma	0.00235	0.00523	CbGeAlD
Thioridazine—CHRM2—central nervous system—malignant glioma	0.00235	0.00523	CbGeAlD
Thioridazine—KCNH2—medulla oblongata—malignant glioma	0.00235	0.00523	CbGeAlD
Thioridazine—DRD1—brain—malignant glioma	0.00232	0.00516	CbGeAlD
Thioridazine—HTR7—midbrain—malignant glioma	0.00231	0.00513	CbGeAlD
Thioridazine—CYP2E1—telencephalon—malignant glioma	0.0023	0.00512	CbGeAlD
Thioridazine—HTR2C—central nervous system—malignant glioma	0.00227	0.00505	CbGeAlD
Thioridazine—HTR2A—brainstem—malignant glioma	0.00226	0.00502	CbGeAlD
Thioridazine—HTR7—spinal cord—malignant glioma	0.00225	0.005	CbGeAlD
Thioridazine—DRD2—midbrain—malignant glioma	0.00218	0.00485	CbGeAlD
Thioridazine—HTR2A—retina—malignant glioma	0.00218	0.00484	CbGeAlD
Thioridazine—KCNH2—midbrain—malignant glioma	0.00215	0.00478	CbGeAlD
Thioridazine—KCNH2—spinal cord—malignant glioma	0.0021	0.00466	CbGeAlD
Thioridazine—CYP2D6—brainstem—malignant glioma	0.00206	0.00457	CbGeAlD
Thioridazine—Pancytopenia—Carmustine—malignant glioma	0.00203	0.02	CcSEcCtD
Thioridazine—Sweating increased—Temozolomide—malignant glioma	0.00202	0.0198	CcSEcCtD
Thioridazine—HTR2A—telencephalon—malignant glioma	0.002	0.00445	CbGeAlD
Thioridazine—Pancytopenia—Temozolomide—malignant glioma	0.00197	0.0193	CcSEcCtD
Thioridazine—HTR1A—central nervous system—malignant glioma	0.00191	0.00425	CbGeAlD
Thioridazine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00189	0.0186	CcSEcCtD
Thioridazine—Weight increased—Temozolomide—malignant glioma	0.00188	0.0185	CcSEcCtD
Thioridazine—CHRM2—brain—malignant glioma	0.00187	0.00416	CbGeAlD
Thioridazine—HTR1A—cerebellum—malignant glioma	0.00187	0.00415	CbGeAlD
Thioridazine—ADRA2A—medulla oblongata—malignant glioma	0.00185	0.00411	CbGeAlD
Thioridazine—Ethopropazine—BCHE—malignant glioma	0.00183	0.105	CrCbGaD
Thioridazine—HTR7—central nervous system—malignant glioma	0.00183	0.00406	CbGeAlD
Thioridazine—CYP2D6—telencephalon—malignant glioma	0.00182	0.00406	CbGeAlD
Thioridazine—CYP2E1—medulla oblongata—malignant glioma	0.00181	0.00403	CbGeAlD
Thioridazine—HTR2C—brain—malignant glioma	0.0018	0.00401	CbGeAlD
Thioridazine—HTR7—cerebellum—malignant glioma	0.00178	0.00397	CbGeAlD
Thioridazine—ADRA1A—central nervous system—malignant glioma	0.00176	0.00391	CbGeAlD
Thioridazine—DRD2—central nervous system—malignant glioma	0.00173	0.00384	CbGeAlD
Thioridazine—ADRA1A—cerebellum—malignant glioma	0.00172	0.00383	CbGeAlD
Thioridazine—KCNH2—central nervous system—malignant glioma	0.0017	0.00378	CbGeAlD
Thioridazine—ADRA2A—midbrain—malignant glioma	0.00169	0.00376	CbGeAlD
Thioridazine—Oedema peripheral—Carmustine—malignant glioma	0.00169	0.0166	CcSEcCtD
Thioridazine—DRD2—cerebellum—malignant glioma	0.00169	0.00375	CbGeAlD
Thioridazine—KCNH2—cerebellum—malignant glioma	0.00166	0.0037	CbGeAlD
Thioridazine—ADRA2A—spinal cord—malignant glioma	0.00165	0.00367	CbGeAlD
Thioridazine—Oedema peripheral—Temozolomide—malignant glioma	0.00163	0.016	CcSEcCtD
Thioridazine—CYP2E1—spinal cord—malignant glioma	0.00161	0.00359	CbGeAlD
Thioridazine—Eletriptan—PTGS1—malignant glioma	0.00159	0.0915	CrCbGaD
Thioridazine—HTR2A—medulla oblongata—malignant glioma	0.00157	0.0035	CbGeAlD
Thioridazine—Clomipramine—GSTP1—malignant glioma	0.00153	0.0882	CrCbGaD
Thioridazine—Arrhythmia—Carmustine—malignant glioma	0.00153	0.015	CcSEcCtD
Thioridazine—HTR1A—brain—malignant glioma	0.00152	0.00337	CbGeAlD
Thioridazine—Perphenazine—CYP2C18—malignant glioma	0.0015	0.0864	CrCbGaD
Thioridazine—Mental disorder—Carmustine—malignant glioma	0.0015	0.0148	CcSEcCtD
Thioridazine—Triflupromazine—BCHE—malignant glioma	0.0015	0.0861	CrCbGaD
Thioridazine—Erythema—Carmustine—malignant glioma	0.00149	0.0147	CcSEcCtD
Thioridazine—Mental disorder—Temozolomide—malignant glioma	0.00145	0.0143	CcSEcCtD
Thioridazine—HTR7—brain—malignant glioma	0.00145	0.00322	CbGeAlD
Thioridazine—Erythema—Temozolomide—malignant glioma	0.00144	0.0142	CcSEcCtD
Thioridazine—HTR2A—midbrain—malignant glioma	0.00144	0.0032	CbGeAlD
Thioridazine—Vision blurred—Carmustine—malignant glioma	0.00141	0.0138	CcSEcCtD
Thioridazine—HTR2A—spinal cord—malignant glioma	0.0014	0.00312	CbGeAlD
Thioridazine—Tremor—Carmustine—malignant glioma	0.0014	0.0137	CcSEcCtD
Thioridazine—ADRA1A—brain—malignant glioma	0.0014	0.00311	CbGeAlD
Thioridazine—Anaemia—Carmustine—malignant glioma	0.00138	0.0136	CcSEcCtD
Thioridazine—Agitation—Carmustine—malignant glioma	0.00137	0.0135	CcSEcCtD
Thioridazine—DRD2—brain—malignant glioma	0.00137	0.00305	CbGeAlD
Thioridazine—HRH1—central nervous system—malignant glioma	0.00136	0.00303	CbGeAlD
Thioridazine—Vision blurred—Temozolomide—malignant glioma	0.00136	0.0134	CcSEcCtD
Thioridazine—Tremor—Temozolomide—malignant glioma	0.00135	0.0133	CcSEcCtD
Thioridazine—KCNH2—brain—malignant glioma	0.00135	0.003	CbGeAlD
Thioridazine—ADRA2A—central nervous system—malignant glioma	0.00134	0.00298	CbGeAlD
Thioridazine—Leukopenia—Carmustine—malignant glioma	0.00134	0.0131	CcSEcCtD
Thioridazine—Anaemia—Temozolomide—malignant glioma	0.00133	0.0131	CcSEcCtD
Thioridazine—Agitation—Temozolomide—malignant glioma	0.00133	0.013	CcSEcCtD
Thioridazine—Angioedema—Temozolomide—malignant glioma	0.00132	0.0129	CcSEcCtD
Thioridazine—CYP2E1—central nervous system—malignant glioma	0.00131	0.00291	CbGeAlD
Thioridazine—ADRA2A—cerebellum—malignant glioma	0.00131	0.00291	CbGeAlD
Thioridazine—Leukopenia—Temozolomide—malignant glioma	0.00129	0.0127	CcSEcCtD
Thioridazine—CYP2E1—cerebellum—malignant glioma	0.00128	0.00285	CbGeAlD
Thioridazine—CYP2C8—brain—malignant glioma	0.00124	0.00275	CbGeAlD
Thioridazine—Confusional state—Carmustine—malignant glioma	0.00123	0.0121	CcSEcCtD
Thioridazine—Oedema—Carmustine—malignant glioma	0.00122	0.012	CcSEcCtD
Thioridazine—Thrombocytopenia—Carmustine—malignant glioma	0.00119	0.0117	CcSEcCtD
Thioridazine—Tachycardia—Carmustine—malignant glioma	0.00119	0.0117	CcSEcCtD
Thioridazine—Confusional state—Temozolomide—malignant glioma	0.00119	0.0117	CcSEcCtD
Thioridazine—Oedema—Temozolomide—malignant glioma	0.00118	0.0116	CcSEcCtD
Thioridazine—Anorexia—Carmustine—malignant glioma	0.00116	0.0114	CcSEcCtD
Thioridazine—Thrombocytopenia—Temozolomide—malignant glioma	0.00115	0.0113	CcSEcCtD
Thioridazine—Promethazine—CYP2B6—malignant glioma	0.00114	0.0657	CrCbGaD
Thioridazine—HTR2A—central nervous system—malignant glioma	0.00114	0.00253	CbGeAlD
Thioridazine—Hypotension—Carmustine—malignant glioma	0.00114	0.0112	CcSEcCtD
Thioridazine—Hyperhidrosis—Temozolomide—malignant glioma	0.00114	0.0112	CcSEcCtD
Thioridazine—Anorexia—Temozolomide—malignant glioma	0.00112	0.011	CcSEcCtD
Thioridazine—Perphenazine—CYP2B6—malignant glioma	0.00112	0.0641	CrCbGaD
Thioridazine—HTR2A—cerebellum—malignant glioma	0.00111	0.00247	CbGeAlD
Thioridazine—Somnolence—Carmustine—malignant glioma	0.00108	0.0106	CcSEcCtD
Thioridazine—HRH1—brain—malignant glioma	0.00108	0.00241	CbGeAlD
Thioridazine—ADRA2A—brain—malignant glioma	0.00106	0.00236	CbGeAlD
Thioridazine—Decreased appetite—Carmustine—malignant glioma	0.00106	0.0104	CcSEcCtD
Thioridazine—Somnolence—Temozolomide—malignant glioma	0.00105	0.0103	CcSEcCtD
Thioridazine—Constipation—Carmustine—malignant glioma	0.00104	0.0102	CcSEcCtD
Thioridazine—CYP2E1—brain—malignant glioma	0.00104	0.00231	CbGeAlD
Thioridazine—CYP2D6—central nervous system—malignant glioma	0.00104	0.00231	CbGeAlD
Thioridazine—Decreased appetite—Temozolomide—malignant glioma	0.00102	0.0101	CcSEcCtD
Thioridazine—CYP2D6—cerebellum—malignant glioma	0.00101	0.00225	CbGeAlD
Thioridazine—Constipation—Temozolomide—malignant glioma	0.00101	0.00989	CcSEcCtD
Thioridazine—Feeling abnormal—Carmustine—malignant glioma	0.001	0.00986	CcSEcCtD
Thioridazine—Feeling abnormal—Temozolomide—malignant glioma	0.00097	0.00953	CcSEcCtD
Thioridazine—Body temperature increased—Carmustine—malignant glioma	0.000963	0.00946	CcSEcCtD
Thioridazine—Body temperature increased—Temozolomide—malignant glioma	0.000931	0.00914	CcSEcCtD
Thioridazine—HTR2A—brain—malignant glioma	0.000904	0.00201	CbGeAlD
Thioridazine—Hypersensitivity—Carmustine—malignant glioma	0.000898	0.00882	CcSEcCtD
Thioridazine—Hypersensitivity—Temozolomide—malignant glioma	0.000867	0.00852	CcSEcCtD
Thioridazine—Diarrhoea—Carmustine—malignant glioma	0.000834	0.00819	CcSEcCtD
Thioridazine—CYP2D6—brain—malignant glioma	0.000823	0.00183	CbGeAlD
Thioridazine—Diarrhoea—Temozolomide—malignant glioma	0.000805	0.00791	CcSEcCtD
Thioridazine—Vomiting—Carmustine—malignant glioma	0.000775	0.00761	CcSEcCtD
Thioridazine—Rash—Carmustine—malignant glioma	0.000768	0.00754	CcSEcCtD
Thioridazine—Dermatitis—Carmustine—malignant glioma	0.000767	0.00754	CcSEcCtD
Thioridazine—Headache—Carmustine—malignant glioma	0.000763	0.0075	CcSEcCtD
Thioridazine—Vomiting—Temozolomide—malignant glioma	0.000749	0.00735	CcSEcCtD
Thioridazine—Rash—Temozolomide—malignant glioma	0.000742	0.00729	CcSEcCtD
Thioridazine—Dermatitis—Temozolomide—malignant glioma	0.000742	0.00728	CcSEcCtD
Thioridazine—Headache—Temozolomide—malignant glioma	0.000737	0.00724	CcSEcCtD
Thioridazine—Nausea—Carmustine—malignant glioma	0.000724	0.00711	CcSEcCtD
Thioridazine—Chlorpromazine—BCHE—malignant glioma	0.000723	0.0415	CrCbGaD
Thioridazine—Nausea—Temozolomide—malignant glioma	0.000699	0.00687	CcSEcCtD
Thioridazine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	2.4e-05	6e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	2.4e-05	6e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	2.39e-05	5.98e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.39e-05	5.98e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—malignant glioma	2.39e-05	5.98e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—malignant glioma	2.38e-05	5.97e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—FGF2—malignant glioma	2.38e-05	5.96e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CB—malignant glioma	2.36e-05	5.92e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—malignant glioma	2.36e-05	5.92e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	2.36e-05	5.91e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	2.35e-05	5.89e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—FGF2—malignant glioma	2.34e-05	5.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—malignant glioma	2.34e-05	5.87e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	2.34e-05	5.85e-05	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	2.34e-05	5.85e-05	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	2.32e-05	5.82e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—malignant glioma	2.31e-05	5.79e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—malignant glioma	2.31e-05	5.78e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	2.3e-05	5.76e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—malignant glioma	2.3e-05	5.76e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—malignant glioma	2.3e-05	5.75e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NCOR1—malignant glioma	2.29e-05	5.74e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.29e-05	5.74e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—malignant glioma	2.28e-05	5.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	2.28e-05	5.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MDM2—malignant glioma	2.27e-05	5.68e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	2.27e-05	5.68e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RAF1—malignant glioma	2.26e-05	5.66e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—malignant glioma	2.26e-05	5.66e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—KRAS—malignant glioma	2.25e-05	5.65e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—KRAS—malignant glioma	2.25e-05	5.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.25e-05	5.63e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.24e-05	5.61e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	2.24e-05	5.6e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	2.24e-05	5.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.23e-05	5.59e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MDM2—malignant glioma	2.23e-05	5.58e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.23e-05	5.57e-05	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	2.22e-05	5.57e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RAF1—malignant glioma	2.22e-05	5.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	2.22e-05	5.56e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	2.21e-05	5.53e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CAV1—malignant glioma	2.21e-05	5.53e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	2.2e-05	5.52e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.2e-05	5.51e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.2e-05	5.51e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—malignant glioma	2.2e-05	5.51e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB2—malignant glioma	2.2e-05	5.5e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	2.2e-05	5.5e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	2.19e-05	5.49e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CAV1—malignant glioma	2.19e-05	5.48e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	2.19e-05	5.48e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—malignant glioma	2.19e-05	5.47e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.19e-05	5.47e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	2.19e-05	5.47e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	2.18e-05	5.46e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.18e-05	5.45e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTEN—malignant glioma	2.17e-05	5.44e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.17e-05	5.44e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.17e-05	5.44e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CB—malignant glioma	2.17e-05	5.44e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	2.17e-05	5.43e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.16e-05	5.41e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.16e-05	5.41e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	2.16e-05	5.4e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.15e-05	5.39e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—malignant glioma	2.15e-05	5.39e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.13e-05	5.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	2.13e-05	5.33e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.12e-05	5.31e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.12e-05	5.31e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—malignant glioma	2.11e-05	5.28e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.11e-05	5.28e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—malignant glioma	2.1e-05	5.26e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.09e-05	5.23e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.09e-05	5.23e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.08e-05	5.22e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.08e-05	5.21e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	2.07e-05	5.19e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.07e-05	5.18e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	2.07e-05	5.18e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—malignant glioma	2.05e-05	5.14e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.05e-05	5.13e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.05e-05	5.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.04e-05	5.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—malignant glioma	2.04e-05	5.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.04e-05	5.11e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.03e-05	5.09e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.03e-05	5.09e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—malignant glioma	2.03e-05	5.08e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.02e-05	5.07e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	2.02e-05	5.06e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.02e-05	5.05e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.01e-05	5.04e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.01e-05	5.03e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—malignant glioma	2e-05	5.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2e-05	5.02e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—malignant glioma	2e-05	5.01e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2e-05	5e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—malignant glioma	2e-05	5e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1.98e-05	4.96e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.98e-05	4.95e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.98e-05	4.95e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.96e-05	4.92e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	1.96e-05	4.91e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—malignant glioma	1.96e-05	4.91e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.96e-05	4.9e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.95e-05	4.89e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	1.95e-05	4.89e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.94e-05	4.87e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—malignant glioma	1.94e-05	4.86e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—malignant glioma	1.94e-05	4.86e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	1.93e-05	4.84e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—malignant glioma	1.92e-05	4.82e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.92e-05	4.81e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—malignant glioma	1.92e-05	4.81e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—malignant glioma	1.91e-05	4.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.9e-05	4.76e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.89e-05	4.73e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—malignant glioma	1.88e-05	4.72e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.88e-05	4.7e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.88e-05	4.7e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—malignant glioma	1.88e-05	4.7e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—malignant glioma	1.87e-05	4.69e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAV1—malignant glioma	1.87e-05	4.68e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.87e-05	4.68e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	1.86e-05	4.66e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—malignant glioma	1.86e-05	4.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	1.85e-05	4.64e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.85e-05	4.64e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.85e-05	4.63e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	1.84e-05	4.62e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.84e-05	4.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.84e-05	4.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.83e-05	4.59e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	1.83e-05	4.58e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.82e-05	4.55e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.82e-05	4.55e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—malignant glioma	1.81e-05	4.52e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	1.8e-05	4.5e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—malignant glioma	1.8e-05	4.5e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.79e-05	4.49e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.79e-05	4.47e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	1.78e-05	4.46e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.77e-05	4.43e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.77e-05	4.42e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	1.76e-05	4.4e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.75e-05	4.39e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—malignant glioma	1.73e-05	4.32e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	1.72e-05	4.32e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.72e-05	4.31e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.72e-05	4.3e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.71e-05	4.28e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—malignant glioma	1.71e-05	4.27e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.7e-05	4.27e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.7e-05	4.25e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	1.69e-05	4.24e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—malignant glioma	1.69e-05	4.24e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—malignant glioma	1.69e-05	4.23e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.68e-05	4.21e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.68e-05	4.2e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—malignant glioma	1.68e-05	4.2e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.68e-05	4.19e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.67e-05	4.18e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.67e-05	4.17e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.67e-05	4.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.66e-05	4.16e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.66e-05	4.16e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—malignant glioma	1.66e-05	4.16e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.65e-05	4.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.64e-05	4.12e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—malignant glioma	1.64e-05	4.12e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—malignant glioma	1.62e-05	4.06e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.59e-05	3.98e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—malignant glioma	1.59e-05	3.97e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—malignant glioma	1.56e-05	3.91e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—malignant glioma	1.56e-05	3.9e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—malignant glioma	1.55e-05	3.88e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.54e-05	3.86e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.54e-05	3.86e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.53e-05	3.84e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—malignant glioma	1.53e-05	3.84e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.53e-05	3.83e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.53e-05	3.83e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.53e-05	3.82e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.53e-05	3.82e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.53e-05	3.82e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.53e-05	3.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—malignant glioma	1.52e-05	3.81e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—malignant glioma	1.51e-05	3.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.5e-05	3.75e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.5e-05	3.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.49e-05	3.74e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—malignant glioma	1.48e-05	3.71e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.48e-05	3.7e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—malignant glioma	1.47e-05	3.67e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.46e-05	3.66e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—malignant glioma	1.46e-05	3.65e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—malignant glioma	1.45e-05	3.62e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.44e-05	3.61e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.44e-05	3.61e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.44e-05	3.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.42e-05	3.55e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.42e-05	3.54e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.41e-05	3.54e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.41e-05	3.54e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.39e-05	3.48e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.35e-05	3.37e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—malignant glioma	1.33e-05	3.33e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.32e-05	3.32e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.32e-05	3.31e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.32e-05	3.31e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—malignant glioma	1.32e-05	3.3e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.31e-05	3.28e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.31e-05	3.27e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—malignant glioma	1.3e-05	3.26e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.3e-05	3.26e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.3e-05	3.25e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.29e-05	3.24e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.28e-05	3.21e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—malignant glioma	1.28e-05	3.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.26e-05	3.15e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.25e-05	3.14e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.25e-05	3.14e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.25e-05	3.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.21e-05	3.02e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.19e-05	2.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—malignant glioma	1.18e-05	2.95e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.17e-05	2.92e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.14e-05	2.86e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—malignant glioma	1.13e-05	2.82e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.1e-05	2.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.08e-05	2.71e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—malignant glioma	1.08e-05	2.71e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.08e-05	2.7e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.06e-05	2.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.06e-05	2.65e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.02e-05	2.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	9.85e-06	2.47e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.39e-06	2.35e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—malignant glioma	9.35e-06	2.34e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—malignant glioma	9.31e-06	2.33e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—malignant glioma	8.34e-06	2.09e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—malignant glioma	7.96e-06	1.99e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—malignant glioma	7.67e-06	1.92e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—malignant glioma	7.61e-06	1.9e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—malignant glioma	6.5e-06	1.63e-05	CbGpPWpGaD
